Skip to content

The safety and efficacy of modified passive leg raising test in neurocritically ill patients

The safety and efficacy of modified passive leg raising test in neurocritically ill patients

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300076742
Enrollment
Unknown
Registered
2023-10-17
Start date
2023-11-01
Completion date
Unknown
Last updated
2023-10-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute brain injury, acute circulatory failure

Interventions

Test group:The experiment is divided into three stages, namely the standard passive leg lift test stage, the improved passive leg lift test stage, and the fluid replacement test stage. The order of th

Sponsors

the First Affiliated Hospital of University of Science and Technology of China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Age greater than or equal to 18 years old Patients with acute brain injury (including traumatic brain injury, hemorrhagic stroke, ischemic stroke, aneurysmal subarachnoid hemorrhage) Patients with acute circulatory failure (mean arterial pressure =65mmHg and/or systolic blood pressure =90mmHg and/or hyperlactatemia =2mmol/L and/or vasoactive drugs are used to maintain blood pressure)

Exclusion criteria

Exclusion criteria: Acute brain herniation caused by severe brain injury Intracranial pressure greater than 22mmHg Cerebral perfusion pressure lower than 60mmHg Acoustic window of the brain (temporal window) is poorly transparent, unable to perform effective transcranial Doppler ultrasonography Abdominal hypertension (intra-abdominal pressure = 15mmHg) Acute right heart failure (transthoracic echocardiography shows that the right ventricle is enlarged (end-diastolic basal segment diameter = 4.1 cm, right ventricle/left ventricular end-diastolic diameter ratio = 0.7), right ventricular systolic function is reduced (tricuspid valve ring systolic displacement =1.6cm), with/without tricuspid regurgitation, pulmonary hypertension, dilated inferior vena cava) Lower extremity deep vein thrombosis Pregnant or lactating women

Design outcomes

Primary

MeasureTime frame
cardiac index;end-tidal partial pressure of carbon dioxide;Sensitivity and specificity of diagnostic methods;

Secondary

MeasureTime frame
Cerebral blood flow velocity in M1 segment of middle cerebral artery;Brain regional oxygenation saturation in bilateral frontal lobes;

Countries

China

Contacts

Public ContactTang Rui

The First Affiliated Hospital of USTC

drtangru@ustc.edu.cn+86 186 5655 3280

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026